Staff View for: Issues relating to ephedra-containing di

 Staff view

You must be logged in to Tag Records

Issues relating to ephedra-containing dietary supplements : hearings before the Subcommittee on Oversight and Investigations and the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives ; One Hundred Eighth Congress, first session ; July 23 and 24, 2003.

Book Cover
Published: Washington : U.S. Government Printing Office, 2003.
Topics: Ephedra - Side effects. | Drug approval - United States. | Dietary supplements - United States. | Food additives - United States. | Weight loss preparations - United States.
Regions: United States.
Tags: Add


Spaces will separate tags.
Use quotes for multi-word tags.


000 02877cam a2200589Ii 4500
001 17893088
005 20180824194114.0
006 m o d f
007 cr mnu---uuaun
008 040114s2003 dcua ob f000 0 eng d
019 |a654323783
020 |a0160710480
020 |a9780160710483
035 |a(OCoLC)ocm54022599
035 |a(UISdb)813518
037 |a552-070-30618-8|bGPO
040 |aBUF|beng|epn|cBUF|dOCLCQ|dOCLCE|dOCLCQ|dOCLCO|dCWCLL|dOCLCQ|dOCLCF|dUISdb
043 |an-us---
049 |aIASB
050 4|aKF27|b.E5546 2003e
074 |a1019-A-01
074 |a1019-A-01 (online)
074 |a1019-B-01 (MF)
074 |a1019-B-01 (online)
082 04|a348.01
086 0 |aY 4.C 73/8:108-43
088 |aSerial no. 108-43 (United States. Congress. House. Committee on Energy and Commerce)
110 1 |aUnited States.|bCongress.|bHouse.|bCommittee on Energy and Commerce.|bSubcommittee on Oversight and Investigations.
245 10|aIssues relating to ephedra-containing dietary supplements :|bhearings before the Subcommittee on Oversight and Investigations and the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives ; One Hundred Eighth Congress, first session ; July 23 and 24, 2003.
246 3 |aEphedra-containing dietary supplements
264 1|aWashington :|bU.S. Government Printing Office,|c2003.
300 |a1 online resource (iii, 266 pages) :|billustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"Serial no. 108-43."
504 |aIncludes bibliographical references.
588 |aPrint version record; online resource viewed March 31, 2016.
650 0|aEphedra|xSide effects.
650 0|aDrug approval|zUnited States.
650 0|aDietary supplements|zUnited States.
650 0|aFood additives|zUnited States.
650 0|aWeight loss preparations|zUnited States.
650 7|aDietary supplements.|2fast|0(OCoLC)fst00893336
650 7|aDrug approval.|2fast|0(OCoLC)fst00898661
650 7|aFood additives.|2fast|0(OCoLC)fst00930654
650 7|aWeight loss preparations.|2fast|0(OCoLC)fst01173471
651 7|aUnited States.|2fast|0(OCoLC)fst01204155
710 1 |aUnited States.|bCongress.|bHouse.|bCommittee on Energy and Commerce.|bSubcommittee on Commerce, Trade, and Consumer Protection.
776 08|iPrint version:|aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.|tIssues relating to ephedra-containing dietary supplements.|dWashington : U.S.G.P.O. : For sale by the Supt. of Docs., U.S.G.P.O., 2003|w(DLC) 2003505192|w(OCoLC)53884392
856 41|uhttp://purl.access.gpo.gov/GPO/LPS41610|zUS GPO
994 |aC0|bIAS

Staff View for: Issues relating to ephedra-containing di